<DOC>
	<DOCNO>NCT00222495</DOCNO>
	<brief_summary>The overall goal study determine efficacy tolerability three atypical antipsychotic medication ( risperidone , olanzapine , quetiapine ) treatment adolescent psychosis . It hypothesize three medication equally effective reduce symptoms psychosis .</brief_summary>
	<brief_title>A Comparative Study New Medications Psychosis Adolescents</brief_title>
	<detailed_description>The purpose study compare efficacy tolerance three atypical antipsychotic , medication use last 10 year , treatment psychosis adolescent . Efficacy refers well medication work decrease symptom associate schizophrenia , tolerance refers level side effect compliance take medication . All three medication demonstrate efficacy treat psychosis without cause extra pyramidal side effect ( uncontrolled muscle movement ) associate typical , old antipsychotic medication . Young people may great risk side effect typical antipsychotic medication . There study efficacy tolerance among patient 18-years-old take three drug study : risperidone , olanzapine , quetiapine . However , time little data available compare three medication . This study open-label , random assignment , 12-week study ass efficacy tolerance three atypical antipsychotic medication treatment adolescent ( age 12-18 ) schizophrenia psychosis . The participant inform medication she/he taking , assign medication randomly ( base chance rather choice ) . There additional theoretical belief regard study well . A secondary hypothesis study quetiapine less extra pyramidal side effect ( EPS ) less prolactin-related side effect risperidone . A third hypothesis quetiapine lead less weight gain olanzapine risperidone . Finally , hypothesize few side effect , quetiapine well tolerate risperidone olanzapine .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>1 . Subjects age 1218 diagnosis psychotic illness . 2 . Subject currently meet criterion one follow disorder : schizophrenia , schizoaffective disorder ( mainly schizophrenic ) , schizophreniform disorder , psychosis NOS . 3 . Subject good physical health suffer medical disorder might mimic psychosis lead medical difficulty study medication . 4 . If subject take antipsychotic medication study entry , medicine discontinue 14 day depend symptom . 1 . Subject medical disorder would interfere study , epilepsy , thyroid disease , liver disease , AIDS , etc . 2 . Subject currently substance dependence . 3 . Subject talk medication inhibits induce cytochrome P450 3A4 ( specific medication list Appendix protocol ) . 3 . Subject meet criteria brief psychosis mood disorder psychotic feature . 4 . Female subject pregnant nursing .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>Psychotic Disorders adolescent</keyword>
	<keyword>Schizophrenia adolescent</keyword>
	<keyword>Schizophreniform Disorders adolescent</keyword>
	<keyword>Schizoaffective Disorders adolescent</keyword>
</DOC>